Cell & Gene Therapy International 2025 Set to Unite Global Leaders in Advanced Therapies in Boston

Boston, MA – The future of medicine is coming to Boston this September as Cell & Gene Therapy International 2025 takes place from September 16–18, 2025, at the Hynes Convention Center, Boston, MA. With the theme “From Breakthrough Science to Life-Changing Treatments”, this year’s event will bring together global experts, pioneering technologies, and breakthrough strategies to accelerate targeted therapies, optimize scalability, and expand patient access like never before.

The event is expected to welcome more than 800 attendees from leading biopharma companies and CGT startups, along with 220 sponsors and exhibitors and over 80 industry experts presenting across three tracks. These tracks will cover cell therapy manufacturing and analytics, gene therapy manufacturing and analytics, and the development of emerging cell and gene therapies. 

Attendees will explore proven strategies to scale autologous, allogeneic, and gene-edited manufacturing, accelerate production through breakthrough upstream and downstream innovations, and unlock the future of advanced therapies using AI-driven solutions, gene editing, and transformative technologies. To further boost learning, two brand-new workshops will be offered: the Potency Masterclass and Mastering CDMO Partnerships & External Tech Transfers.

Beyond the core sessions, Cell & Gene Therapy International 2025 offers a complete event experience. The “ConnectMe — Digital Networking Platform” is already live, allowing attendees to build profiles, schedule meetings, and connect with peers ahead of time. With AI-powered matchmaking, real-time updates, and instant meeting scheduling, networking begins weeks before the event. 

On-site, attendees can look forward to poster presentations that showcase the latest research, a bustling exhibit hall with 220+ exhibitors and live lab tours featuring exclusive product demos, and an unforgettable networking night at the Museum of Science designed to spark meaningful connections. This year will also debut the highly anticipated Investor and Big Pharma panels, offering insights on funding landscapes, strategic partnerships, and how to position for success.

Every registration includes full access to all conference sessions, interactive discussions, and networking opportunities, along with 12 months of on-demand recordings for continued learning. Attendees will also benefit from co-location with BioProcess International, gaining access to additional sessions and networking opportunities at no extra cost.

Cell & Gene Therapy International 2025 is more than an event, it is where science, technology, and networking meet to create real-world impact. By bringing together leaders in R&D, manufacturing, analytics, supply chain, and investment, the event will help the cell and gene therapy community boost efficiency, reduce costs, and scale smarter, ensuring these life-changing treatments become more accessible worldwide.

As the official Media Partner, Pharma Now will provide extensive coverage of Cell & Gene Therapy International 2025. From highlighting key sessions and speaker insights to amplifying event announcements and breakthrough discussions, Pharma Now will ensure that the conversations and innovations shaping the future of cell and gene therapy reach a wider global audience.